{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:03:11Z","timestamp":1792623791338,"version":"4.5.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The concepts of myocardial infarction with non-obstructive coronary arteries (MINOCA) are now widely accepted. Calcium channel blockers (CCBs) are the first-line medication for coronary spastic angina (coronary spastic angina: CSA\/vasospastic angina: VSA), while \u03b2-blockers sometimes do not improve CSA\/VSA. However, \u03b2-blockers are essential for managing symptoms of coronary microvascular dysfunction and considered vital for treating heart failure with reduced ejection fraction (HFrEF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We present the case of an 83-year-old female admitted with shortness of breath persisting for over 1\u2005year and worsening ejection fraction (EF) from 65% to 32%. On admission, she experienced chest pain at rest despite finding no significant stenosis on coronary angiography. Several days later, we performed functional coronary angiography (FCA), revealing diffuse epicardial coronary spasm upon injecting acetylcholine. The coronary flow reserve was 4.4 (\u22672.0), and the microvascular resistance index was 20 (&amp;lt;25). We diagnosed the patient with a myocardial injury event induced by CSA\/VSA and initiated dihydropyridine CCBs. A few months later, her chest pain resolved; the HF symptoms improved (NYHA: from \u2162 to \u2161), accompanied by a reduction in B-type natriuretic peptide levels (from 4561.2 to 75.4\u2005pg\/mL) and EF improvement (from 32.0% to 62.6%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>We managed a patient with HFrEF and MINOCA. Although CCBs are not routinely recommended for HFrEF, we added dihydropyridine CCBs to treat CSA\/VSA based on comprehensive diagnostic procedures. This approach sedated chest pain and may have contributed to her EF improvement. Detailed examinations and tailored treatment strategies might be helpful for HF treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae540","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T12:57:21Z","timestamp":1727528241000},"source":"Crossref","is-referenced-by-count":2,"title":["Managing heart failure with reduced ejection fraction merged with myocardial infarction with non-obstructive coronary arteries: a case report"],"prefix":"10.1093","volume":"8","author":[{"given":"So","family":"Ikebe","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-9228","authenticated-orcid":false,"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]},{"name":"Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-259X","authenticated-orcid":false,"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556 ,","place":["Japan"]},{"name":"Center of Metabolic Regulation of Healthy Aging, Faculty of Life Sciences, Kumamoto University Hospital , 1-1-1 Honjo, Chuo-ku, Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"2024102417230434500_ytae540-B1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","article-title":"Heart failure drug treatment: the fantastic four","volume":"42","author":"Johann","year":"2021","journal-title":"Eur Heart J"},{"key":"2024102417230434500_ytae540-B2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024102417230434500_ytae540-B3","first-page":"e891","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Jacqueline","year":"2019","journal-title":"Circulation"},{"key":"2024102417230434500_ytae540-B4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1253\/circj.CJ-22-0779","article-title":"JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction","volume":"87","author":"Hokimoto","year":"2023","journal-title":"Circ J"},{"key":"2024102417230434500_ytae540-B5","first-page":"e618","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Kristian","year":"2018","journal-title":"Circulation"},{"key":"2024102417230434500_ytae540-B6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2796.2012.02591.x","article-title":"Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA)","volume":"273","author":"John","year":"2013","journal-title":"J Intern Med"},{"key":"2024102417230434500_ytae540-B7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/eurheartj\/ehz403","article-title":"Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population","volume":"41","author":"Rachel","year":"2020","journal-title":"Euro Heart J"},{"key":"2024102417230434500_ytae540-B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2018.03.056","article-title":"Predictors of adverse outcome in patients with myocardial infarction with non-obstructive coronary artery (MINOCA) disease","volume":"261","author":"Nordenskj\u00f6ld","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024102417230434500_ytae540-B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcmg.2023.05.016","article-title":"Prognostic role of early cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries","volume":"17","author":"Luca","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024102417230434500_ytae540-B10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/ejhf.2271","article-title":"Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)","volume":"23","author":"Gianluigi","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2024102417230434500_ytae540-B11","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Alexandre","year":"2022","journal-title":"Lancet"},{"key":"2024102417230434500_ytae540-B12","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2014digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"2024102417230434500_ytae540-B13","first-page":"573","article-title":"Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test","volume":"57","author":"Io","year":"2007","journal-title":"Arzneimittelforschung"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae540\/59401429\/ytae540.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/10\/ytae540\/60052734\/ytae540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/8\/10\/ytae540\/60052734\/ytae540.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T17:23:40Z","timestamp":1729790620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae540\/7787549"}},"subtitle":[],"editor":[{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Luigi Di","family":"Serafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Georgios","family":"Benetos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Abdullah","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae540","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,28]]},"article-number":"ytae540"}}